Research Site

Wodonga 3690

1 studies enrolling now · 6 studies all time

What they study most

Breast Neoplasms, Colorectal Cancer, Lung Cancer, Mantle Cell Lymphoma (MCL), Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer

Studies at this site

• Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations — Recruiting now
• An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma — Running, not enrolling
• Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients — Completed
• Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy — Completed
• First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX — Completed
• Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study — Completed